TY - JOUR
KW - 3383:Drug & Alcohol Rehabilitation
KW - Adulthood (18 yrs & older)
KW - Agonist Scale
KW - article
KW - buprenorphine
KW - buprenorphine transdermal formulation
KW - Detoxification
KW - Drug Abuse
KW - drug efficacy
KW - Drug Rehabilitation
KW - drug safety
KW - Drug Therapy
KW - drug tolerance
KW - Drug Withdrawal
KW - Empirical Study
KW - Female
KW - Human
KW - Male
KW - Middle Age (40-64 yrs)
KW - Modified Himmelsbach Withdrawal Severity Scale
KW - Opiates
KW - opioid detoxification
KW - opioid withdrawal
KW - Quantitative Study
KW - Safety
KW - Thirties (30-39 yrs)
KW - Treatment Effectiveness Evaluation
KW - Treatment Outcome/Clinical Trial
KW - Visual Analogue Scale
KW - Withdrawal Scale
KW - Young Adulthood (18-29 yrs)
AU - Ryan K. Lanier
AU - Annie Umbricht
AU - Joseph A. Harrison
AU - Elie S. Nuwayser
AU - George E. Bigelow
A1 - 
BT - Psychopharmacology
C5 - Opioids & Substance Use
CP - 2
IS - 2
JF - Psychopharmacology
PB - Springer
PY - 2008
SN - 0033-3158, 0033-3158
SP - 149
EP - 158
EP - 
T1 - Opioid detoxification via single 7-day application of a buprenorphine transdermal patch: An open-label evaluation.
T2 - Psychopharmacology
TI - Opioid detoxification via single 7-day application of a buprenorphine transdermal patch: An open-label evaluation.
U1 - Opioids & Substance Use
UR - http://search.proquest.com/docview/621987515?accountid=28100
VL - 198
VO - 0033-3158, 0033-3158
Y1 - 2008
ER -